Marleen van de Sande

MD PhD

Medical Specialist, AII - Immunology AMS - Fundamental Research Affiliatie UvA Medical Specialist, Clinical Immunology and Rheumatology

PI

Specialization

rheumatologist

Focus of research

My clinical and translational research line is focussed on the immunopathogenesis of early (pre-clinical) spondyloarthritis, from the at-risk phase onwards.

Keywords: spondyloarthritis, synovial inflammation, synovial biopsy, at-risk phase of arthritis, psoriatic arthritis, clincal trials

Active member of: ASAS (Assessment of SpondyloArthritis international Society), GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis), Eular Synovitis Study Group (ESSG), EuroSpA research collaboration network

Key publications
Latest publications

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study
Christiansen, S. N., Rasmussen, S. H., Ostergaard, M., Pons, M., Michelsen, B., Pavelka, K., Codreanu, C., Ciurea, A., Glintborg, B., Santos, M. J., Sari, I., Rotar, Z., Gudbjornsson, B., Macfarlane, G. J., Relas, H., Iannone, F., Laas, K., Wallman, J. K., van de Sande, M., Provan, S. A., & 19 othersCastrejon, I., Zavada, J., Mogosan, C., Nissen, M. J., Loft, A. G., Barcelos, A., Erez, Y., Pirkmajer, K. P., Grondal, G., Jones, G. T., Hokkanen, A-M., Chimenti, M. S., Vorobjov, S., Giuseppe, D. D., Kvien, T. K., Otero-Varela, L., van der Horst-Bruinsma, I., Hetland, M. L. & Ørnbjerg, L. M., 24 Jul 2024, In: RMD open. 10, 3, e004166.
Research output: Contribution to journal › Article › Academic › peer-review
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment
Ørnbjerg, L. M., Brahe, C. H., Linde, L., Jacobsson, L., Nissen, M. J., Kristianslund, E. K., Santos, M. J., Nordström, D., Rotar, Z., Gudbjornsson, B., Onen, F., Codreanu, C., Lindström, U., Möller, B., Kvien, T. K., Barcelos, A., Eklund, K. K., Tomšič, M., Love, T. J., Can, G., & 14 othersIonescu, R., Loft, A. G., Mann, H., Pavelka, K., van de Sande, M., van der Horst-Bruinsma, I. E., Suarez, M. P., Sánchez-Piedra, C., Macfarlane, G. J., Iannone, F., Michelsen, B., Hyldstrup, L. H., Østergaard, M. & Hetland, M. L., 1 Jul 2024, In: Joint, bone, spine. 91, 4, 105729.
Research output: Contribution to journal › Article › Academic › peer-review
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
Linde, L., Ørnbjerg, L. M., Georgiadis, S., Rasmussen, S. H., Lindström, U., Askling, J., Michelsen, B., di Giuseppe, D., Wallman, J. K., Gudbjornsson, B., Love, T. J., Nordström, D. C., Yli-Kerttula, T., Nekvindová, L., Vencovský, J., Iannone, F., Cauli, A., Loft, A. G., Glintborg, B., Laas, K., & 13 othersRotar, Z., Tomšič, M., MacFarlane, G. J., Möller, B., van de Sande, M., Codreanu, C., Nissen, M. J., Birlik, M., Erten, S., Santos, M. J., Vieira-Sousa, E., Hetland, M. L. & Østergaard, M., 1 Mar 2024, In: Rheumatology (United Kingdom). 63, 3, p. 751-764 14 p.
Research output: Contribution to journal › Article › Academic › peer-review
All publications

Marleen van de Sande

Specialization

Focus of research

Immunopathology of synovitis: from histology to molecular pathways

Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort

First-degree relatives of axial spondyloarthritis patients of the pre-SpA cohort would consider using medication in a preventive setting

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

Marleen van de Sande

Specialization

Focus of research

Immunopathology of synovitis: from histology to molecular pathways

Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort

First-degree relatives of axial spondyloarthritis patients of the pre-SpA cohort would consider using medication in a preventive setting

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

We use cookies